These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17283327)

  • 1. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
    Chang GY
    Neurology; 2007 Feb; 68(6):471-2; author reply 472. PubMed ID: 17283327
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
    Davis SM; Broderick J; Hennerici M; Brun NC; Diringer MN; Mayer SA; Begtrup K; Steiner T;
    Neurology; 2006 Apr; 66(8):1175-81. PubMed ID: 16636233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute intracerebral hemorrhage.
    Auriel E; Bornstein NM
    Isr Med Assoc J; 2006 Nov; 8(11):812-4. PubMed ID: 17180837
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2008 May; 358(20):2127-37. PubMed ID: 18480205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant factor VIIa in a thrombocytopenic patient with spontaneous intracerebral haemorrhage.
    Busani S; Marietta M; Pasetto A; Girardis M
    Thromb Haemost; 2005 Feb; 93(2):381-2. PubMed ID: 15711759
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2005 Feb; 352(8):777-85. PubMed ID: 15728810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma.
    Altuncu E; Berrak S; Bilgen H; Yurdakul Z; Canpolat C; Ozek E
    J Matern Fetal Neonatal Med; 2007 Aug; 20(8):627-9. PubMed ID: 17674281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of subdural hematoma with increased mortality in lobar intracerebral hemorrhage.
    Patel PV; FitzMaurice E; Nandigam RN; Auluck P; Viswanathan A; Goldstein JN; Rosand J; Greenberg SM; Smith EE
    Arch Neurol; 2009 Jan; 66(1):79-84. PubMed ID: 19139303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of haemophilia treatment for intracerebral haemorrhage.
    Lowe R
    Lancet Neurol; 2004 Aug; 3(8):448. PubMed ID: 15303268
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Friedrich JO
    N Engl J Med; 2005 May; 352(20):2133-4; author reply 2133-4. PubMed ID: 15901870
    [No Abstract]   [Full Text] [Related]  

  • 11. Nontraumatic acute subdural hematoma. A case report and review of the literature.
    Avis SP
    Am J Forensic Med Pathol; 1993 Jun; 14(2):130-4. PubMed ID: 8328432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA
    Stroke; 2007 Feb; 38(2 Suppl):763-7. PubMed ID: 17261734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa for rapid reversal of anticoagulant effect in patients with intracranial hemorrhage: the Israeli experience and review of the literature.
    Da'as N; Misgav M; Kalish Y; Varon D
    Isr Med Assoc J; 2006 Nov; 8(11):807-11. PubMed ID: 17180836
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy.
    Mayer SA
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S235-40. PubMed ID: 12404092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes.
    Emlet LL; Crippen D
    Crit Care; 2006 Feb; 10(1):304. PubMed ID: 16420665
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracerebral hemorrhage--improving outcome by reducing volume?
    Tuhrim S
    N Engl J Med; 2008 May; 358(20):2174-6. PubMed ID: 18480212
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
    Cruz-Flores S
    Neurology; 2007 May; 68(20):1750-1; author reply 1751. PubMed ID: 17502566
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultra-early hemostatic therapy for acute intracerebral hemorrhage.
    Mayer SA; Rincon F
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S70-6. PubMed ID: 16427389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
    Mayer SA;
    Neurology; 2007 Jul; 69(3):319-20. PubMed ID: 17636075
    [No Abstract]   [Full Text] [Related]  

  • 20. [Formation of the chronic subdural hematoma: 2. A patho-anatomical study of sequel of the traumatic acute subdural hemorrhage (author's transl)].
    Ito U; Fujimoto T; Inaba Y
    No Shinkei Geka; 1974 Feb; 2(2):129-43. PubMed ID: 4474616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.